The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Changes in network activity with the progression of Parkinson's disease
Open accessAbstract
Parkinson's disease (PD) is associated with abnormal activity in spatially distributed neural systems mediating the motor and cognitive manifestations of this disorder. Metabolic PET studies have demonstrated that this illness is characterized by a set of reproducible functional brain networks that correlate with these clinical features. The time at which these abnormalities appear is unknown, as is their relationship to concurrent clinical and dopaminergic indices of disease progression. In this longitudinal study, 15 early stage PD patients (age 58.0 +/- 10.2 years; Hoehn and Yahr Stage 1.2 +/- 0.3) were enrolled within 2 years of diagnosis. The subjects underwent multitracer PET imaging at baseline, 24 and 48 months. At each timepoint they were scanned with [18F]-fluorodeoxyglucose (FDG) to assess longitudinal changes in regional glucose utilization and in the expression of the PD-related motor (PDRP) and cognitive metabolic covariance patterns (PDCP). At each timepoint the subjects also underwent PET imaging with [18F]-fluoropropyl betaCIT (FP-CIT) to quantify longitudinal changes in caudate and putamen dopamine transporter (DAT) binding. Regional metabolic changes across the three timepoints were localized using statistical parametric mapping (SPM). Longitudinal changes in regional metabolism and network activity, caudate/putamen DAT binding, and Unified Parkinson's Disease Rating Scale (UPDRS) motor ratings were assessed using repeated measures analysis of variance (RMANOVA). Relationships between these measures of disease progression were assessed by computing within-subject correlation coefficients. We found that disease progression was associated with increasing metabolism in the subthalamic nucleus (STN) and internal globus pallidus (GPi) (P < 0.001), as well as in the dorsal pons and primary motor cortex (P < 0.0001). Advancing disease was also associated with declining metabolism in the prefrontal and inferior parietal regions (P < 0.001). PDRP expression was elevated at baseline relative to healthy control subjects (P < 0.04), and increased progressively over time (P < 0.0001). PDCP activity also increased with time (P < 0.0001). However, these changes in network activity were slower than for the PDRP (P < 0.04), reaching abnormal levels only at the final timepoint. Changes in PDRP activity, but not PDCP activity, correlated with concurrent declines in striatal DAT binding (P < 0.01) and increases in motor ratings (P < 0.005). Significant within-subject correlations (P < 0.01) were also evident between the latter two progression indices. The early stages of PD are associated with progressive increases and decreases in regional metabolism at key nodes of the motor and cognitive networks that characterize the illness. Potential disease-modifying therapies may alter the time course of one or both of these abnormal networks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378
Frequency Dependence of Signal Power and Spatial Reach of the Local Field Potential
Leski, S., Lindén, H., Tetzlaff, T., Pettersen, K. H., & Einevoll, G. T. (2013) · PubMed · doi:10.18154/rwth-conv-084442 · Cited by 3,639
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
FEARNLEY, J. M., & LEES, A. J. (1991) · Brain · doi:10.1093/brain/114.5.2283 · Cited by 3,529
Unified Parkinson's Disease Rating Scale
(2012) · SpringerReference · doi:10.1007/springerreference_184495 · Cited by 3,066
Recent developments in Parkinson's disease
Fahn, S., Elton, R., MARSDEN, C. D., Calne, D. B., & Goldstein, M. (1986) · Raven Press eBooks · Cited by 2,306
Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop
Parent, A., & Hazrati, L.-N. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(94)00007-c · Cited by 2,161
Basal ganglia and cerebellar loops: motor and cognitive circuits
Middleton, F. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00040-5 · Cited by 1,940
Levodopa and the Progression of Parkinson's Disease
(2004) · New England Journal of Medicine · doi:10.1056/nejmoa033447 · Cited by 1,821
Effects of Tocopherol and Deprenyl on the Progression of Disability in Early Parkinson's Disease
(1993) · New England Journal of Medicine · doi:10.1056/nejm199301213280305 · Cited by 1,221
De Cocker, L. J. L., van Veluw, S. J., Fowkes, M., Luijten, P. R., Mali, W. P. T. M., & Hendrikse, J. (2013) · Cerebrovascular Diseases · doi:10.1159/000353668 · Cited by 1,156
Calculating correlation coefficients with repeated observations: Part 2—correlation between subjects
Bland, J. M., & Altman, D. G. (1995) · BMJ · doi:10.1136/bmj.310.6980.633 · Cited by 1,082
Bland, J. M., & Altman, D. G. (1995) · BMJ · doi:10.1136/bmj.310.6977.446 · Cited by 1,034
Functional anatomy of the basal ganglia
Yelnik, J. (2002) · Movement Disorders · doi:10.1002/mds.10138 · Cited by 952
Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study
Whone, A. L., Watts, R. L., Stoessl, A. J., Davis, M., Reske, S., Nahmias, C., Lang, A. E., Rascol, O., Ribeiro, M. J., Remy, P., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10609 · Cited by 829
Three-Dimensional MRI Atlas of the Human Cerebellum in Proportional Stereotaxic Space
Schmahmann, J. D., Doyon, J., McDonald, D., Holmes, C., Lavoie, K., Hurwitz, A. S., Kabani, N., Toga, A., Evans, A., & Petrides, M. (1999) · NeuroImage · doi:10.1006/nimg.1999.0459 · Cited by 781
Dependence of subthalamic nucleus oscillations on movement and dopamine in Parkinson’s disease
Levy, R., Ashby, P., Hutchison, W. D., Lang, A. E., Lozano, A. M., & Dostrovsky, J. O. (2002) · Brain · doi:10.1093/brain/awf128 · Cited by 683
The subthalamic nucleus in the context of movement disorders
Hamani, C. (2004) · Brain · doi:10.1093/brain/awh029 · Cited by 585
MRI Atlas of the Human Cerebellum
Schmahmann, J. D., Doyon, J., Toga, A. W., Petrides, M., & Evans, A. C. (2000) · Cited by 575
Cognitive status correlates with neuropathologic stage in Parkinson disease
Braak, H., Rüb, U., Jansen Steur, E. N. H., Del Tredici, K., & de Vos, R. A. I. (2005) · Neurology · doi:10.1212/01.wnl.0000158422.41380.82 · Cited by 560
Jueptner, M., & Weiller, C. (1995) · NeuroImage · doi:10.1006/nimg.1995.1017 · Cited by 517
Morrish, P. K., Rakshi, J. S., Bailey, D. L., Sawle, G. V., & Brooks, D. J. (1998) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.3.314 · Cited by 510
Seibyl, J. P., Marchek, K. L., Quinlan, D., Sheff, K., Zoghbi, S., Zea‐Ponce, Y., Baldwin, R. M., Fussell, B., Smith, E. O., Charney, D. S., et al. (1995) · Annals of Neurology · doi:10.1002/ana.410380407 · Cited by 467
The metabolic topography of parkinsonism
Eidelberg, D., Moeller, J. R., Dhawan, V., Spetsieris, P., Takikawa, S., Ishikawa, T., Chaly, T., Robeson, W., Margouleff, D., Przedborski, S., et al. (1994) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1994.99 · Cited by 455
Self-citationChanges in motor subtype and risk for incident dementia in Parkinson's disease
Alves, G., Larsen, J. P., Emre, M., Wentzel‐Larsen, T., & Aarsland, D. (2006) · Movement Disorders · doi:10.1002/mds.20897 · Cited by 434
Functional Decline in Parkinson Disease
Jankovic, J., & Kapadia, A. S. (2001) · Archives of Neurology · doi:10.1001/archneur.58.10.1611 · Cited by 427
The heterogeneity of Parkinson's disease: Clinical and prognostic implications
Zetusky, W. J., Jankovic, J., & Pirozzolo, F. J. (1985) · Neurology · doi:10.1212/wnl.35.4.522 · Cited by 380
The role of radiotracer imaging in Parkinson disease
Ravina, B., Eidelberg, D., Ahlskog, J. E., Albin, R. L., Brooks, D. J., Carbon, M., Dhawan, V., Feigin, A., Fahn, S., Guttman, M., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000149403.14458.7f · Cited by 374
Self-citationMetabolic brain networks associated with cognitive function in Parkinson's disease
Huang, C., Mattis, P., Tang, C., Perrine, K., Carbon, M., & Eidelberg, D. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2006.09.003 · Cited by 361
Self-citationNetwork modulation in the treatment of Parkinson's disease
Asanuma, K. (2006) · Brain · doi:10.1093/brain/awl162 · Cited by 358
Presymptomatic compensation in Parkinson's disease is not dopamine-mediated
Bezard, E., Gross, C. E., & Brotchie, J. M. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00038-9 · Cited by 350
Abnormal Metabolic Network Activity in Parkinson'S Disease: Test—Retest Reproducibility
Ma, Y., Tang, C., Spetsieris, P. G., Dhawan, V., & Eidelberg, D. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600358 · Cited by 312
Self-citationGoldberg, J. A., Boraud, T., Maraton, S., Haber, S. N., Vaadia, E., & Bergman, H. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-11-04639.2002 · Cited by 306
Hilker, R., Schweitzer, K., Coburger, S., Ghaemi, M., Weisenbach, S., Jacobs, A. H., Rudolf, J., Herholz, K., & Heiss, W.-D. (2005) · Archives of Neurology · doi:10.1001/archneur.62.3.378 · Cited by 293
Progression of motor impairment and disability in Parkinson disease: A population-based study
Alves, G., Wentzel-Larsen, T., Aarsland, D., & Larsen, J. P. (2005) · Neurology · doi:10.1212/01.wnl.0000183359.50822.f2 · Cited by 271
Pathophysiology of Parkinson's Disease: The MPTP Primate Model of the Human Disorder
WICHMANN, T., & DeLONG, M. R. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07477.x · Cited by 255
Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease
BROOKS, D. (2003) · Experimental Neurology · doi:10.1016/j.expneurol.2003.08.008 · Cited by 233
Takikawa, S., Dhawan, V, Spetsieris, P., Robeson, W., Chaly, T., Dahl, R., Margouleff, D., & Eidelberg, D. (1993) · Radiology · doi:10.1148/radiology.188.1.8511286 · Cited by 208
Self-citationNetwork modulation by the subthalamic nucleus in the treatment of Parkinson's disease
Trošt, M., Su, S., Su, P., Yen, R.-F., Tseng, H.-M., Barnes, A., Ma, Y., & Eidelberg, D. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2005.12.024 · Cited by 165
Self-citationImaging of dopamine transporters with iodine-123-beta-CIT and SPECT in Parkinson's disease.
Asenbaum, S., Brücke, T., Pirker, W., Podreka, I., Angelberger, P., Wenger, S., Wöber, C., Müller, F. M., & Deecke, L. (1997) · PubMed · Cited by 163
Hilker, R., Voges, J., Ghaemi, M., Lehrke, R., Rudolf, J., Koulousakis, A., Herholz, K., Wienhard, K., Sturm, V., & Heiss, W. (2002) · Movement Disorders · doi:10.1002/mds.10297 · Cited by 161
Blaha, C. D., & Winn, P. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-03-01035.1993 · Cited by 148
Emborg, M. E., Carbon, M., Holden, J. E., During, M. J., Ma, Y., Tang, C., Moirano, J. M., Fitzsimons, H. L., Roitberg, B. Z., Tüccar, E., et al. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600364 · Cited by 146
Self-citationMetabolic correlates of pallidal neuronal activity in Parkinson's disease
Eidelberg, D., Moeller, J. R., Kazumata, K., Antonini, A., Sterio, D., Dhawan, V., Spetsieris, P., Alterman, R., Kelly, P. J., Dogali, M., et al. (1997) · Brain · doi:10.1093/brain/120.8.1315 · Cited by 141
Self-citationMentis, M. J., McIntosh, A. R., Perrine, K., Dhawan, V., Berlin, B., Feigin, A., Edwards, C., Mattis, P., & Eidelberg, D. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.5.746 · Cited by 136
Self-citationAssessment of disease severity in parkinsonism with fluorine-18-fluorodeoxyglucose and PET.
Eidelberg, D., Moeller, J. R., Ishikawa, T., DHAWAN, V. M., Spetsieris, P. G., Chaly, T., Robeson, W., Dahl, J., & Margouleff, D. (1995) · PubMed · Cited by 136
Self-citationLevodopa and the progression of Parkinson’s disease
Morgan, J. C., & Sethi, K. D. (2005) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-005-0069-1 · Cited by 123
Palombo, E., Porrino, L. J., Bankiewicz, K. S., Crane, A., Sokoloff, L., & Kopin, I. J. (1990) · Journal of Neuroscience · doi:10.1523/jneurosci.10-03-00860.1990 · Cited by 120
Carbon, M., Ma, Y., Barnes, A., DHAWAN, V. M., Chaly, T., Ghilardi, M. F., & Eidelberg, D. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2003.12.014 · Cited by 112
Self-citationExecutive processes in Parkinson's disease: FDG‐PET and network analysis
Lozza, C., Baron, J., Eidelberg, D., Mentis, M. J., Carbon, M., & Marié, R. (2004) · Human Brain Mapping · doi:10.1002/hbm.20033 · Cited by 112
Self-citationReproducibility of Regional Metabolic Covariance Patterns: Comparison of Four Populations
Eidelberg, D., Moeller, J. R., DHAWAN, V. M., Antonini, A., MORAN, L., Missimer, J. H., & Leenders, K. L. (1998) · Elsevier eBooks · doi:10.1016/b978-012161340-2/50039-1 · Cited by 112
Self-citationMetabolic effects of nigrostriatal denervation in basal ganglia
Hirsch, É. C., Perier, C., Orieux, G., François, C., Féger, J., Yelnik, J., Vila, M., Lévy, R., TOLOSA, E. S., Marín, C., et al. (2000) · Trends in Neurosciences · doi:10.1016/s1471-1931(00)00021-5 · Cited by 108
Parametric mapping of [18F]FPCIT binding in early stage Parkinson's disease: A PET study
Ma, Y., DHAWAN, V. M., Mentis, M. J., Chaly, T., Spetsieris, P. G., & Eidelberg, D. (2002) · Synapse · doi:10.1002/syn.10090 · Cited by 98
Self-citationTc‐99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism
Feigin, A., Antonini, A., Fukuda, M., Notaris, R. D., Benti, R., Pezzoli, G., Mentis, M. J., Moeller, J. R., & Eidelberg, D. (2002) · Movement Disorders · doi:10.1002/mds.10270 · Cited by 89
Self-citationDementia in Parkinson's disease: cause and treatment
Emre, M. (2004) · Current Opinion in Neurology · doi:10.1097/01.wco.0000137529.30750.ab · Cited by 88
Nurmi, E., Bergman, J., Eskola, O., Solin, O., Vahlberg, T., Sonninen, P., & Rinne, J. (2003) · Synapse · doi:10.1002/syn.10192 · Cited by 82
Learning networks in health and Parkinson's disease: Reproducibility and treatment effects
Carbon, M., Ghilardi, M. F., Feigin, A., Fukuda, M., Silvestri, G., Mentis, M. J., Ghez, C. P., Moeller, J. R., & Eidelberg, D. (2003) · Human Brain Mapping · doi:10.1002/hbm.10115 · Cited by 81
Self-citationQuantification of Parkinson’s disease-related network expression with ECD SPECT
Eckert, T., Laere, K. V., Tang, C., Lewis, D. E., Edwards, C., Santens, P., & Eidelberg, D. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0261-9 · Cited by 76
Self-citationNeuroimaging and therapeutics in movement disorders
Eckert, T., & Eidelberg, D. (2005) · NeuroRx · doi:10.1602/neurorx.2.2.361 · Cited by 73
Self-citationFunctional imaging of cognition in Parkinson's disease
Carbon, M., & Marié, R. (2003) · Current Opinion in Neurology · doi:10.1097/01.wco.0000084225.82329.3c · Cited by 69
Blinded positron emission tomography study of dopamine cell implantation for Parkinson's disease
Nakamura, T., Dhawan, V., Chaly, T., Fukuda, M., Ma, Y., Breeze, R., Greene, P., Fahn, S., Freed, C., & Eidelberg, D. (2001) · Annals of Neurology · doi:10.1002/ana.1075 · Cited by 67
Self-citationDivergent expression of regional metabolic topographies in Parkinson's disease and normal ageing
Moeller, J. R., & Eidelberg, D. (1997) · Brain · doi:10.1093/brain/120.12.2197 · Cited by 67
Self-citationThe metabolic pathology of dopa‐responsive dystonia
Asanuma, K., Ma, Y., Huang, C. C., Carbon‐Correll, M., Edwards, C., Raymond, D., Bressman, S., Moeller, J. R., & Eidelberg, D. (2005) · Annals of Neurology · doi:10.1002/ana.20442 · Cited by 66
Self-citationHilker, R., Voges, J., Thiel, A., Ghaemi, M., Herholz, K., Sturm, V., & Heiss, W. (2002) · Journal of Neural Transmission · doi:10.1007/s00702-002-0696-5 · Cited by 51
Parkinson's disease: in vivo assessment of disease progression using positron emission tomography
Au, W. L., Adams, J. R., Troiano, A. R., & Stoessl, A. J. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.09.028 · Cited by 49
Carlson, J. D., Pearlstein, R. D., Buchholz, J. N., Iacono, R. P., & Maeda, G. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01268-8 · Cited by 43
Guimarães, P., Kieburtz, K. D., Goetz, C. G., Elm, J. J., Palesch, Y. Y., Huang, P., Ravina, B. M., Tanner, C. M., & Tilley, B. C. (2005) · Clinical Trials · doi:10.1191/1740774505cn125oa · Cited by 31
Correlates of movement initiation and velocity in Parkinson's disease: A longitudinal PET study
Carbon, M., Ghilardi, M. F., DHAWAN, V. M., & Eidelberg, D. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.08.019 · Cited by 31
Self-citationDopamine agonists and Parkinson's disease progression: What can we learn from neuroimaging studies
MAREK, K. L., Jennings, D. L., & Seibyl, J. P. (2003) · Annals of Neurology · doi:10.1002/ana.10486 · Cited by 30
Highly-automated computer-aided diagnosis of neurological disorders using functional brain imaging
Spetsieris, P. G., Ma, Y., DHAWAN, V. M., Moeller, J. R., & Eidelberg, D. (2006) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.654467 · Cited by 29
Self-citationHardie, R. J., & Morrish, P. (1999) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.66.2.256 · Cited by 28
Functional brain imaging in Parkinson's disease.
Carbon, M., Edwards, C., & Eidelberg, D. (2003) · PubMed · Cited by 19
Self-citationMixed models and multiple comparisons in analysis of human neurochemical maps
Ellis, S. P., Underwood, M. D., Arango, V., & Mann, J. J. (2000) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(00)00051-2 · Cited by 16
Huang, C. C., Mattis, P. J., & Julin, P. (2007) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2007.05.003 · Cited by 14
Self-citation
Cited by
Cognitive decline in Parkinson disease
Aarsland, D., Creese, B., Politis, M., Chaudhuri, K. R., ffytche, D. H., Weintraub, D., & Ballard, C. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.27 · Cited by 1,027
The cerebellum in Parkinson’s disease
Wu, T., & Hallett, M. (2013) · Brain · doi:10.1093/brain/aws360 · Cited by 748
Missing pieces in the Parkinson's disease puzzle
Obeso, J. A., Rodriguez-Oroz, M. C., Goetz, C. G., Marin, C., Kordower, J. H., Rodriguez, M., Hirsch, E. C., Farrer, M., Schapira, A. H. V., & Halliday, G. (2010) · Nature Medicine · doi:10.1038/nm.2165 · Cited by 734
Determinants of dopaminergic neuron loss in Parkinson's disease
Surmeier, D. J. (2018) · The FEBS Journal · doi:10.1111/febs.14607 · Cited by 444
Brain-First versus Gut-First Parkinson’s Disease: A Hypothesis
Borghammer, P., & Van Den Berge, N. (2019) · Journal of Parkinson’s Disease · doi:10.3233/jpd-191721 · Cited by 419
Metadata
- Authors
- Huang, C., Tang, C., Feigin, A., Lesser, M., Ma, Y., Pourfar, M., Dhawan, V., & Eidelberg, D.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-05-29
- Volume
- 130
- Issue
- 7
- Pages
- 1834-1846
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2117277050
- Cited by
- 395
- References
- 73
- FWCI
- 18.22
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.